These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Ligands for mapping alphavbeta3-integrin expression in vivo. Schottelius M; Laufer B; Kessler H; Wester HJ Acc Chem Res; 2009 Jul; 42(7):969-80. PubMed ID: 19489579 [TBL] [Abstract][Full Text] [Related]
7. Fast clearing RGD-based near-infrared fluorescent probes for in vivo tumor diagnosis. Cao J; Wan S; Tian J; Li S; Deng D; Qian Z; Gu Y Contrast Media Mol Imaging; 2012; 7(4):390-402. PubMed ID: 22649045 [TBL] [Abstract][Full Text] [Related]
8. FITC-conjugated cyclic RGD peptides as fluorescent probes for staining integrin αvβ3/αvβ5 in tumor tissues. Zheng Y; Ji S; Czerwinski A; Valenzuela F; Pennington M; Liu S Bioconjug Chem; 2014 Nov; 25(11):1925-41. PubMed ID: 25312799 [TBL] [Abstract][Full Text] [Related]
9. In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in brain tumor xenografts. Chen X; Conti PS; Moats RA Cancer Res; 2004 Nov; 64(21):8009-14. PubMed ID: 15520209 [TBL] [Abstract][Full Text] [Related]
10. Near-infrared fluorescence imaging of tumor integrin alpha v beta 3 expression with Cy7-labeled RGD multimers. Wu Y; Cai W; Chen X Mol Imaging Biol; 2006; 8(4):226-36. PubMed ID: 16791749 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and evaluation of near infrared fluorescent multimeric RGD peptides for targeting tumors. Ye Y; Bloch S; Xu B; Achilefu S J Med Chem; 2006 Apr; 49(7):2268-75. PubMed ID: 16570923 [TBL] [Abstract][Full Text] [Related]
12. In Vivo Characterization of 4 Lobeek D; Franssen GM; Ma MT; Wester HJ; Decristoforo C; Oyen WJG; Boerman OC; Terry SYA; Rijpkema M J Nucl Med; 2018 Aug; 59(8):1296-1301. PubMed ID: 29626124 [TBL] [Abstract][Full Text] [Related]